Add to ORKGBackground: The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposure prophylaxis (PrEP) has shown promising results in recent trials. To understand the potential impact of PrEP for HIV prevention, in addition to efficacy data, we need to understand both the acceptability of PrEP among members of potential user groups and the factors likely to determine uptake. Methods and findings: Surveys of willingness to use PrEP products were conducted with 1,790 members of potential use
ObjectiveAdoption of pre-exposure prophylaxis (PrEP) to prevent HIV infection has been slow. The pur...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or PrEP, is the use of antiretroviral medicin...
This study was to investigate the prevalence of actual uptake of pre-exposure prophylaxis (PrEP), wi...
The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposur...
BACKGROUND: The use of antiviral medications by HIV negative people to prevent acquisition of HIV or...
Background Although people who use drugs (PWUD) are a key population recommended to receive pre-expo...
<div><p>Introduction</p><p>Pre-exposure prophylaxis (PrEP) is an effective tool to reduce HIV transm...
We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among m...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
PurposePre-exposure prophylaxis (PrEP) is an effective strategy to prevent HIV. However, low uptake ...
We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among m...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
This study examined Pre-Exposure Prophylaxis (PrEP) acceptability among female sex workers, male-to-...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Abstract Background Antiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and rec...
ObjectiveAdoption of pre-exposure prophylaxis (PrEP) to prevent HIV infection has been slow. The pur...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or PrEP, is the use of antiretroviral medicin...
This study was to investigate the prevalence of actual uptake of pre-exposure prophylaxis (PrEP), wi...
The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposur...
BACKGROUND: The use of antiviral medications by HIV negative people to prevent acquisition of HIV or...
Background Although people who use drugs (PWUD) are a key population recommended to receive pre-expo...
<div><p>Introduction</p><p>Pre-exposure prophylaxis (PrEP) is an effective tool to reduce HIV transm...
We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among m...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
PurposePre-exposure prophylaxis (PrEP) is an effective strategy to prevent HIV. However, low uptake ...
We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among m...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
This study examined Pre-Exposure Prophylaxis (PrEP) acceptability among female sex workers, male-to-...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Abstract Background Antiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and rec...
ObjectiveAdoption of pre-exposure prophylaxis (PrEP) to prevent HIV infection has been slow. The pur...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or PrEP, is the use of antiretroviral medicin...
This study was to investigate the prevalence of actual uptake of pre-exposure prophylaxis (PrEP), wi...